Action and Spectrum

Drug Interaction

Adverse Reaction

Frequency not defined:  

Conjunctival hyperemia 

Matrix metalloproteinases 

Cold or profused sweating 

Heavy headache 

Dry mouth 

Vertigo 

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pregnancy consideration: Not enough studies are available for bunazosin, therefore not recommended as initial therapy in pregnant women.  

Lactation: excretion of bunazosin in breast milk is not known.  

Pregnancy category: 

• Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester. 
• Category B: There is no evidence of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women. 
• Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women 
• Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits. 
• Category X: Drugs listed in this category outweigh risks over benefits. These category drugs should be prohibited for pregnant women. 
• Category N: There is no data available for the drug under this category. 

Pharmacology

Adminstartion

Patient Information Leaflet

Patient information leaflet 

Generic Name: Bunazosin 

Pronounced: bunazosin  

Why do we use bunazosin? 

Bunazosin is used for the treatment of glaucoma and hypertension.